1,000+ Opportunities
Find the right grant
Search federal, foundation, and corporate grants with AI — or browse by agency, topic, and state.
The Life Science Research Grant Program is offered by GenScript to fund researchers working in diverse life science fields, including gene and cell therapy, antibody drug discovery, vaccine development, diagnostics, and AI drug discovery. The program provides funding exclusively for purchasing GenScript reagents and services to advance innovative research projects with potential to develop next-generation therapies and vaccines.
Grant amounts range from $5,000 to $100,000 per project, awarded at two intervals annually. Applications are reviewed by GenScript's internal scientific leadership based on scientific merit, potential impact, and alignment with GenScript's areas of interest. Projects should commence within six months of receiving funding and conclude within one year.
Get alerted about grants like this
Save a search for “GenScript” or related topics and get emailed when new opportunities appear.
Search similar grants →Extracted from the official opportunity page/RFP to help you evaluate fit faster.
# 202 5 GenScript Life Science # Research Grant Program 202 5 GenScript Life Science Research Grant Program Grant Application Form Introducing the 202 5 GenScript Life Science Research Grant Program. Recognizing the vital role of research and innovation in driving the next generation of therapies and vaccines, GenScript proudly continues the GenScript Life Science Research Grant Program.
This initiative is designed to empower researchers by offering grant funding specifically for purchasing GenScript reagents and services. Researchers from various life science fields are encouraged to apply and take advantage of this unique opportunity to advance their work. At GenScript, we understand the challenges and importance of advancing scientific knowledge of and developing treatments for life-altering diseases.
In alignment with our commitment to fostering excellence in life sciences research, the GenScript Life Science Research Grant Program aims to catalyze innovation by offering financial support to researchersengaged in projects that can contribute significantly to critical areas of study. Applications for this grant will be reviewed by a diversecommittee comprised of GenScript's internal scientific leadership.
Eachproposal will be reviewed and ranked based on scientific merit, potential for impact, and strategic alignment with GenScript’s primary areas of scientific interest. The application process for the GenScript Life Science Research Grant Program will be transparent, efficient, and managedby a dedicated research grant team.
Detailed information, including official rules, application procedures, documentation requirements, review processes, and decision notifications, will be available on our company website, gen script. com. GenScript is excited to contribute to advancing life sciences research by awarding grants at two pre-determined intervals throughout the year,fostering collaboration and excellence in research.
The deadlines for each submission are as follows: Deadline 1: 6/15/2025 Deadline 2: 11/15/2025 We expect to announce grant recipients within six (6) weeks of each submission deadline.
We look forward to receiving innovative proposals from researchers dedicated to making a positive impact in life science research areas including but not limited to cell and gene therapy, antibody drug discovery, vaccine development , diagnostics, and AI Drug Discovery . Together, let's advance the boundaries of scientific knowledge and bring transformative solutions to the global life science, biotech, and medical communities.
## Application Instructions: Grant applications for the 202 5 GenScript Life Science Research Grant Program must be submitted electronically in English using the portal on the web page: https://www. genscript. com/grantprogram.
html . Alternatively, completed application forms may be submitted to LSRgrant@genscript. com .
Proposed projects should commence within six (6) months of receiving grant funding from GenScript, and research activities should generally take place over one year or less. Please note any planned deviation(s) from these guidelines in the application if applicable. 3.
Institutional Affiliation: 4. Contact Information (Email and Phone): 5. Research Team Members: List names, titles, and roles of all team members involved in the project.
6. Please provide a headshot (png, jpeg, or similar format) with your application. 7.
Project Title: 8. Research Area: Gene and Cell Therapy Antibody Drug Discovery Vaccine Development Others 9. Project Scope (max 250 words): • Briefly describe the goals and objectives of your research project.
10. Research Significance and Key Innovations (max 500 words): • Explain the importance and potential impact of your research in the chosen field and any novel approaches, technologies, or methodologies that set your project apart. 11.
Timeline (max 300 words): • Outline the milestones and key activities with corresponding timelines for your research. 12. Budget Breakdown (max 500 words): This grant is designed to provide funding explicitly designated for purchasing GenScript reagents and services.
Funds are not available to cover indirect costs, such as salaries, to buy products from other companies, or any other expenses. Provide your budget request amount and an estimated list of GenScript reagents and services awarded grant funds would be used for. The maximum budget for each project is set at USD 100,000.
00. Only a few applications will be considered for maximum funding. Various grant funding levels will be considered, including 5,000-10,000, 10,000-50,000, and 50,000-100,000 USD.
Applicants may request a specific funding level; however, GenScript reserves all rights to make the final decision on the funding amount awarded as part of the LSRG program.
## Eligibility and Compliance: Proposals must align with the focus areas of the program in life science research areas including but not limited to gene and cell therapy development, antibody drug discovery, vaccine development , AI-driven drug discovery, or diagnostics. Open to researchers globally. There are no restrictions based on geographic location, and international applicants are encouraged to apply.
Entity Type: Eligible entities include academic/research institutions, universities, biotechnology companies, and other organizations engaged in life sciences research. Any local, state, provincial, federal, or other government or government agency, and officials or employees thereof, are not eligible to participate. Healthcare organizations, including hospitals, healthcare professionals, and employees thereof, are not eligible.
Must be legally recognized and authorized to conduct research in their respective jurisdictions. Affiliation Restrictions: Employees of GenScript or its affiliates, as well as their immediate family members and household members, are ineligible to apply. Each eligible entity may submit only one (1) application representing the sole efforts of that entity.
Collaborations among two (2) or more entities will not be considered unless GenScript provides explicit written consent. Applicants must comply with all applicable federal, state, and local laws and regulations. The program is open to participants worldwide, except where prohibited by law.
Participation constitutes the applicant's full and unconditional agreement to the program's rules and decisions, which are final and binding in all matters related to the grant. GenScript reserves the right to verify the eligibility of applicants and to disqualify any application that does not meet the specified criteria.
The eligibility criteria aim to ensure a fair and open application process for researchers across diverse backgrounds and geographic locations. GenScript reserves the right to make the final determination of funding for the Life Science Research Grant (LSRG) Program. The selection of individuals to receive LSRG awards, the total number of awards, and the amount of funding provided are solely determined by GenScript.
Applicants may request a specific budget based on the proposal submitted during the application process; however, GenScript retains all rights to decide on the funding level and the extent of support provided to each awardee toward services and reagents. 14.
Confidentiality and Conflicts of Interest: Confidentiality Terms: GenScript recognizes the sensitive nature of research proposals and respects the proprietary information submitted by applicants. Therefore, all details provided in the grant applications, including methodologies, data, and preliminary findings, will be treated as confidential.
Notice on Conflicts of Interest: To ensure an unbiased and fair evaluation process, applicants are required to disclose any potential conflicts of interest that may compromise the impartiality of the review.
Conflicts of interest may include, but are not limited to, financial relationships with GenScript, familial or professional relationships with members of the review committee, or any other affiliations that could influence the evaluation process.
In the event of a conflict, GenScript reserves the right to take appropriate measures, including the disqualification of a proposal or the recusal of conflicted individuals from the evaluation process. GenScript is committed to upholding the highest standards of transparency, fairness, and confidentiality throughout the application and evaluation process for the GenScript Life Science Research Grant Program. 15.
Rights and Consent for Use of Participant Information and Project Data: To finalize award distribution, GenScript’s Life Science Research Grant team will present a “Collaboration Agreement” for review to the grant recipients. The agreement aims to ensure that GenScript is publicly recognized in diverse forums for its contribution through the grant program.
GenScript will not request that applicants share intellectual property (IP) rights to their research, findings, or products through this agreement. The awardee would own all rights in performing Services under the LSR Grant Program. I hereby declare that the information provided in this application is true and accurate to the best of my knowledge.
I understand that any misrepresentation may result in disqualification from grant consideration. Applicant Signature: ______________________ 16. Attach any of the following documents: Curriculum Vitae (CV) for each team member (PDF) Itemized Budget Request (PDF) Any additional relevant documents ## Supporting Documents (optional):
Based on current listing details, eligibility includes: Researchers in diverse life science fields. Applicants should confirm final requirements in the official notice before submission.
Current published award information indicates Not specified (funding covers costs associated with GenScript reagents and services) Always verify allowable costs, matching requirements, and funding caps directly in the sponsor documentation.
The current target date is rolling deadlines or periodic funding windows. Build your timeline backwards from this date to cover registrations, approvals, attachments, and final submission checks.
Federal grant success rates typically range from 10-30%, varying by agency and program. Build a strong proposal with clear objectives, measurable outcomes, and a well-justified budget to improve your chances.
Requirements vary by sponsor, but typically include a project narrative, budget justification, organizational capability statement, and key personnel CVs. Check the official notice for the complete list of required attachments.
Yes — AI tools like Granted can help research funders, draft proposal sections, and check compliance. However, always review and customize AI-generated content to reflect your organization's unique strengths and the specific requirements of the solicitation.
Review timelines vary by funder. Federal agencies typically take 3-6 months from submission to award notification. Foundation grants may be faster, often 1-3 months. Check the program's timeline in the official solicitation for specific dates.
Many federal programs offer multi-year funding or allow competitive renewals. Check the official solicitation for continuation and renewal policies. Non-competing continuation applications are common for multi-year awards.
NCI Continuing Umbrella of Research Experiences (CURE) Academic Career Excellence (ACE) Award (K32) is a grant from the National Cancer Institute (NCI) that funds early postdoctoral fellows from diverse backgrounds, including underrepresented groups, to pursue research training in cancer-related fields. The K32 award supports fellows within 12 months prior to transitioning into, or within the first two years of, a postdoctoral position. The program, operated through NCI's Center to Reduce Cancer Health Disparities (CRCHD), aims to enhance the pool of qualified diverse cancer researchers. Beginning with the June 12, 2025 due date, the CURE ACE Award is available in both Independent Clinical Trial Required and Independent Clinical Trial Not Allowed versions. Eligible applicants must be U.S. citizens or permanent residents at time of award.
AAI Career Awards is a grant from the American Association of Immunologists (AAI) that honors members for outstanding research and career achievement. Through multiple award tracks — including the Lifetime Achievement Award, Distinguished Service Award, Distinguished Fellows program, Public Service Award, and Vanguard Award — AAI recognizes immunologists at every career stage who have made exceptional scientific, institutional, or public-policy contributions. Nominations originate from the AAI Council and designated committees. The program celebrates careers defined by scientific excellence, service to the immunology community, and contributions to public advocacy, minority recruitment in the sciences, and disease research. Deadline is September 10, 2025.